ASK PINNACLE · QUESTIONS, EXPLANATIONS & NEXT STEPS
Screen
Explore explanations, everyday questions and next steps connected with screen.
960 published answers · English · Page 28
Causes & influences
Cost-effectiveness of early therapy for Down syndrome in young children
Early therapy for Down syndrome is highly cost-effective: it works during peak brain plasticity, improves communication, mobility and self-care, and reduces lifetime support intensity. Down syndrome is identifiable at birth, so payers can enrol early and track function from a known baseline — making spend predictable and outcomes auditable.
Read the answer AnswerCost-Effectiveness of Early Therapy for Feeding & Eating Difficulties
Early therapy for feeding and eating difficulties in young children is highly cost-effective: it resolves cases in shorter episodes, averts high-cost paediatric admissions and tube-feeding dependence, and protects family productivity. A clinician-set baseline lets payers track resolution against spend.
Read the answer AnswerCost-effectiveness of early therapy for genetic syndromes
Early therapy for children with genetic and chromosomal syndromes is a high-return investment: starting in infancy builds independence, avoids costly secondary complications and lowers lifetime dependency spend. For payers, the key metric is cost per unit of functional independence gained over the life course — on which deferring therapy is the expensive option. Outcomes are tracked via the clinician-administered AbilityScore®.
Read the answer AnswerCost-effectiveness of early therapy for hearing impairment
Early therapy for hearing impairment is highly cost-effective: identifying and treating hearing loss in infancy lets most children develop typical language and enter mainstream schooling, sharply reducing the far larger downstream costs of late identification — special education, lost productivity and lifelong dependency. The greatest payer return comes from funding screening plus early auditory-verbal and speech-language therapy as a single bundled pathway.
Read the answer AnswerCost-effectiveness of early therapy for non-verbal children
Early communication therapy for non-verbal and minimally verbal young children is highly cost-effective: it harnesses peak plasticity for more functional gain per session, deflects the largest downstream costs — intensive schooling, crisis care, lifetime support — and reduces caregiver productivity loss. AAC paired with spoken-language work lets a child communicate now without suppressing speech. Outcomes are measured via a clinician-administered AbilityScore® at a Pinnacle centre.
Read the answer AnswerCost-Effectiveness of Early Therapy for Prematurity-Related Developmental Risk
Early therapy for prematurity-related developmental risk is highly cost-effective: a front-loaded investment during peak neuroplasticity reduces far larger downstream costs in special education, prolonged therapy and supported care, while improving functional independence. The most cost-effective stance is to screen preterm infants early, monitor continuously and intervene before delays compound.
Read the answer AnswerCost-effectiveness of early therapy for Rett Syndrome in young children
For young children with Rett Syndrome (ICD-11 LD90.0), early multidisciplinary therapy is high-value for payers: low-unit-cost recurring contacts in physiotherapy, communication access and feeding support offset much larger downstream costs from scoliosis surgery, aspiration admissions and intensive care. Value is best measured as preserved function and crises averted against a consistent clinician-administered baseline.
Read the answer AnswerCost-effectiveness of early therapy for Sensory-Based Feeding Selectivity
Early therapy for Sensory-Based Feeding Selectivity (ICD-11 6B83) is cost-effective because it intercepts the steep downstream cost curve — faltering-growth workups, dietetic escalation, tube-feeding and entrenched mealtime conflict. Treating early shifts payer spend from crisis care to time-limited developmental support, amplified by caregiver coaching and tracked via a clinician-established functional baseline.
Read the answer AnswerCost-effectiveness of early therapy for Separation Anxiety Disorder
Early therapy for Separation Anxiety Disorder (ICD-11 6B05) in young children is highly cost-effective: it is brief, time-limited, heavily parent-delivered, and prevents the far costlier trajectory of untreated childhood anxiety. The strongest value comes from screening early and routing accurately, so funded therapy reaches children who genuinely need it.
Read the answer AnswerCost-effectiveness of early therapy for Stereotyped Movement Disorder
Early therapy for stereotyped movement disorder (ICD-11 6A06) is highly cost-effective: it uses peak neuroplasticity to reach functional outcomes in fewer sessions and reduces costly downstream supports, especially for self-injurious stereotypies. For payers the meaningful metric is cost per functional outcome over time, anchored by a clinician-administered baseline.
Read the answer AnswerCost-effectiveness of early therapy for Tourette Syndrome in young children
Early behavioural therapy for Tourette Syndrome in young children — chiefly CBIT and habit-reversal — is highly cost-effective for payers because it is time-limited, skills-based and offsets the costlier downstream burden of unmanaged tics, comorbid anxiety and medication. Value is greatest when commissioned as a behaviour-first pathway with baseline-to-outcome measurement.
Read the answer AnswerCost-Effectiveness of Early Therapy for Visual Impairment in Young Children
Early therapy for visual impairment in young children is highly cost-effective because the visual system is most plastic before age 3 and vision underpins motor, language and cognitive learning. Funding early, measurable intervention reduces downstream special-education, secondary-delay and caregiving costs. The clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
Read the answer AnswerAttachment Difficulties in India: prevalence and public-health burden
India has no robust national prevalence figure for Attachment Difficulties (ICD-11 6B44) among young children; the condition is under-recognised in routine data. The real public-health story is that its known risk drivers — institutional care, caregiver mental illness, neglect, poverty and migration — are widespread, making this a preventable, modifiable and inequity-deepening burden best addressed through population screen-and-support.
Read the answer AnswerPrevalence and public-health burden of Auditory Processing Difficulties in India
Reliable India-specific prevalence figures for Auditory Processing Difficulties in young children are not yet established; international estimates suggest roughly 2–5% of school-aged children. The Indian public-health burden is driven by late identification, diagnostic overlap and an audiological surveillance gap — making standardised listening-screening pathways the priority.
Read the answer AnswerCerebral Palsy in India: prevalence and public-health burden
Cerebral Palsy (ICD-11 8D20) is the commonest cause of childhood physical disability, with prevalence around 2–3 per 1,000 live births globally and comparable or higher figures in Indian community studies. Across India's large birth cohort this is a substantial burden, amplified by late identification, uneven early-intervention access, and co-occurring epilepsy, communication and feeding needs.
Read the answer AnswerChildhood Anxiety in India: Prevalence and Public-Health Burden
Childhood anxiety (ICD-11 6B0Z) is among the most common paediatric mental-health conditions, yet in India it is heavily under-counted in young children because national data skew toward adolescents and early presentations are misread as temperament. The public-health burden is cumulative — disrupted learning, school refusal, somatic symptoms and a known trajectory into adult anxiety — making early, non-stigmatising developmental screening the highest-yield policy lever.
Read the answer AnswerChildhood Epilepsy in India: Prevalence and Public-Health Burden
Epilepsy is among the commonest serious neurological conditions of childhood, with active-epilepsy prevalence in India around 3–11 per 1,000 and childhood-onset forms a large share. The defining burden is the treatment gap — many children, especially rural, never receive sustained care. Seizures require prompt medical referral first; developmental support follows. A clinical AbilityScore and diagnosis are formed only at a Pinnacle centre.
Read the answer AnswerChildhood sleep difficulties in India: prevalence and burden
Childhood sleep difficulties affect a substantial minority of young Indian children, with night waking and bedtime resistance most common. The burden spans child development, family wellbeing and avoidable service use, yet most cases are behavioural and respond to caregiver guidance — making brief screening within existing child-health touchpoints a high-yield, low-cost public-health opportunity.
Read the answer AnswerPrevalence and public-health burden of Developmental Regression in India
Developmental regression is not separately counted in India's health statistics, so no exact national prevalence exists; it sits within the broader neurodevelopmental-disability burden, where Indian surveys place such disorders in the low single-digit percentages. Clinically it is a high-priority red flag that warrants prompt medical evaluation first. The public-health burden is driven by under-surveillance, late presentation and uneven access — making early, equitable identification a high-return investment.
Read the answer AnswerDevelopmental Trauma in India: Prevalence and Public-Health Burden
There is no single validated national prevalence figure for developmental trauma in young Indian children, because it describes the developmental impact of chronic early adversity rather than one coded diagnosis. The burden is best understood as scale: ~158 million under-sixes, with substantial exposure to adversity that disrupts early brain development — making it a preventable, high-return target for early-childhood policy.
Read the answer AnswerDown Syndrome in India: Prevalence and Public-Health Burden
Down syndrome occurs at roughly 1 in 1,000 live births; against India's ~23–25 million annual births this is a large, early-identifiable cohort. Its public-health burden lies in the gap between birth and structured early intervention — a high-return target for state-scale developmental infrastructure.
Read the answer AnswerPrevalence and public-health burden of feeding and eating difficulties in India
India has no single national prevalence figure for feeding and eating difficulties (ICD-11 6B8Z), but international estimates of 25–45% in young children and Indian clinic data show a large, under-counted burden that intersects with undernutrition, family stress and missed early-intervention windows — making systematic early screening a public-health priority.
Read the answer AnswerPrevalence & Public-Health Burden of Genetic Syndromes in India
Genetic and chromosomal syndromes affect an estimated 2–3% of live births, translating to a large absolute burden across India's roughly 25 million annual births. Collectively they are a leading cause of childhood intellectual disability and developmental delay, with late identification and uneven regional access being key public-health gaps. The priority response is earlier screening and equitable, scalable early intervention.
Read the answer AnswerHearing Impairment in young children: India's prevalence and public-health burden
Permanent childhood hearing loss affects roughly 1–6 per 1,000 newborns in India, making it among the most prevalent yet most preventable childhood disabilities. Because it is invisible until language fails, undetected loss disrupts speech, literacy and schooling — but early screening linked to the WHO/AAP 1-3-6 pathway makes most of that burden avoidable.
Read the answer